ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
X4 Pharmaceuticals Inc

X4 Pharmaceuticals Inc (XFOR)

4.00
0.12
(3.09%)
終了 6月13日 5:00AM
4.01
0.01
(0.25%)
取引時間後: 8:59AM

X4 Pharmaceuticals Inc (XFOR) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
4.00
( 3.09% )
買値
3.00
売値
4.27
出来高
501,574
3.90 日の範囲 4.02
1.35 52 週間の範囲 4.83
時価総額
前日終値
3.88
始値
3.93
最終取引時間
財務取引量
US$ 1,994,262
VWAP
3.976
平均取引量 (3 か月)
US$ 423,066
発行済株式数
94,319,696
配当利回り
PER
-2.77
1 株当たり利益 (EPS)
-1.38
歳入
9.01M
純利益
-99.72M

X4 Pharmaceuticals Inc について

X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in... X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. It has a license agreement with Abbisko Therapeutics Co Ltd. to manufacture and distribute XOLREMDI in mainland China, Taiwan, Hong Kong and Macau; Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand; and Genzyme Corporation for CXCR4 receptor to develop and commercialize products containing licensed compounds for all therapeutic, prophylactic and diagnostic uses. The company is headquartered in Boston, Massachusetts. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Boston, United States
設立
-
X4 Pharmaceuticals Inc is listed in the Healthcare sector of the ナスダック市場 with ticker XFOR. The last closing price for X4 Pharmaceuticals was US$3.88. Over the last year, X4 Pharmaceuticals shares have traded in a share price range of US$ 1.35 to US$ 4.83.

X4 Pharmaceuticals currently has 94,319,696 shares in issue. The market capitalisation of X4 Pharmaceuticals is US$377.28 million. X4 Pharmaceuticals has a price to earnings ratio (PE ratio) of -2.77.

XFOR 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10044.02023.664405383.80189472CS
40.030.7556675062973.974.363.563899773.94093453CS
12-0.14-3.381642512084.144.663.563916804.1051004CS
260.153.89610389613.854.832.834922283.89100471CS
520.7924.61059190033.214.831.3515090492.99944726CS
1561.7577.77777777782.256.630.170121125361.40295527CS
260-4.605-53.51539802448.6058.80.170116381801.49000817CS

XFOR - Frequently Asked Questions (FAQ)

What is the current X4 Pharmaceuticals Inc share price?
The current share price of X4 Pharmaceuticals Inc is US$ 4.00
How many X4 Pharmaceuticals Inc shares are in issue?
X4 Pharmaceuticals Inc has 94,319,696 shares in issue
What is the market cap of X4 Pharmaceuticals Inc?
The market capitalisation of X4 Pharmaceuticals Inc is USD 377.28M
What is the 1 year trading range for X4 Pharmaceuticals Inc share price?
X4 Pharmaceuticals Inc has traded in the range of US$ 1.35 to US$ 4.83 during the past year
What is the PE ratio of X4 Pharmaceuticals Inc?
The price to earnings ratio of X4 Pharmaceuticals Inc is -2.77
What is the cash to sales ratio of X4 Pharmaceuticals Inc?
The cash to sales ratio of X4 Pharmaceuticals Inc is 40.08
What is the registered address of X4 Pharmaceuticals Inc?
The registered address for X4 Pharmaceuticals Inc is 61 North Beacon Street, Boston, Massachusetts, 02134
What is the X4 Pharmaceuticals Inc website address?
The website address for X4 Pharmaceuticals Inc is www.x4pharma.com
Which industry sector does X4 Pharmaceuticals Inc operate in?
X4 Pharmaceuticals Inc operates in the Biotechnology & Life Sciences sector

XFOR 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

XFOR Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock